01/24/2020
Dr. Clay has joined forces with Forward Science, the manufacturer of OralIDā¢, and became a provider of the ID For Life⢠Program to promote early detection and public awareness of oral cancer in the office. Dr. George W. Clay III, DDS Family Dentistry will be offering enhanced oral cancer screenings during scheduled appointments to new and current patients.
OralIDĀ® uses a proven, optically based technology called,
"fluorescencetechnology." OralIDĀ® fluorescence technology uses a blue light (435ā460 nm) that provides the
clinician an aid in visualization of oral mucosal abnormalities, such as oral cancer and pre-cancer.
*Simply put healthy tissues show up green and reflects light back when using the OralIDĀ® technology, damaged and compromised tissues look darker and do not reflect the same as healthy normal tissue. This allows us to detect abnormalities that would not be visible to the naked eye until the tissue is severly compromised.
Close to 53,000 Americans will be diagnosed with oral or oropharyngeal cancer this year. It will cause over 9,750 deaths, killing roughly 1 person per hour, 24 hours per day. Of those 53,000 newly diagnosed individuals, only slightly more than half will be alive in 5 years.
EARLY DETECTION IS KEY! Currently, 63% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. Finding these abnormalities in much earlier stages can increase the 5-year survival rate up to 80-90%!
OUR GOAL IS NOT TO FIND CANCER. THE OBJECTIVE IS TO FIND ABNORMALITIES BEFORE THEY PROGRESS TO CANCER. YOUR HEALTH AND FUTURE IS VERY IMPORTANT TO US!
Those interested in receiving an oral cancer screening or learning more about our advanced technology implemented at Dr. George W. Clay III, DDS, contact our office at (828) 256-7958 and ask about our OralID screenings, or visit our website at https://georgeclaydentistry.wixsite.com/familycare.
About Forward Science LLC
Forward Science is a biotech company based in Houston, TX. OralID, Forward Scienceās flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Save Lives.⢠by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life⢠Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life⢠Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX).
To learn more about Forward Scienceās ID For Life⢠Program, or any of their products, visit www.ForwardScience.com or call 855-696-7254.